Earnings History Data for Eliem Therapeutics, Inc (ELYM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eliem Therapeutics, Inc

Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-05-2023 AH ELYM Eliem Therapeutics 96.00 -0.84 -0.28 0.00 Eliem Therapeutics GAAP EPS of -$0.84
[5/11/2023 5:46 PM]
3.19 -0.15 
(-4.64%)
0.0 0.0 
(0.00%)
2.21 - 5.42 3,964 0 0
15-08-2022 PM 6:10 AM ET
(Aug 15)
ELYM Eliem Therapeutics 78.00 -0.52 -0.47 0.00 Eliem Therapeutics GAAP EPS of -$0.56 misses by $0.09
[8/15/2022 8:20 AM]
2.90 -0.04 
(-1.36%)
0.0 0.0 
(0.00%)
2.52 - 29.69 27,269 40,000 0
16-05-2022 PM Before the open
(May 16)
ELYM Eliem Therapeutics 105.00 -0.50 -0.57 0.00 Eliem Therapeutics GAAP EPS of -$0.50 beats by $0.06
[5/16/2022 6:26 AM]
3.33 -1.07 
(-24.32%)
3.71 -0.69 
(-15.68%)
2.61 - 29.69 286,908 430,000 10,205
08-11-2021 AH ELYM Eliem Therapeutics 473.00 -0.70 -1.17 0.00 Eliem Therapeutics reports Q3 results
[11/8/2021 5:30 PM]
16.69 0.74 
(4.64%)
15.94 -0.01 
(-0.06%)
13.51 - 29.69 12,648 30,000 100